InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
PBYI
Result 12 decisions over 120 months
Reset filters
Direction ?
Both12 Bought0 Sold12
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: PBYI Minimum: $1M
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
PBYI PUMA BIOTECHNOLOGY, INC.
29 Sep 2017
BRYCE RICHARD PAUL
SR VP, CLINICAL RESEARCH & DEV
Sold, plan not stated
15,000
$1.80M
35.5%
PBYI PUMA BIOTECHNOLOGY, INC.
7 Sep 2017
BRYCE RICHARD PAUL
SR VP, CLINICAL RESEARCH & DEV
Sold, plan not stated
14,000
$1.40M
33.9%
PBYI PUMA BIOTECHNOLOGY, INC.
20 Jul 2017
AUERBACH ALAN H
PRESIDENT AND CEO
Sold, plan not stated 2×
13,175
$1.25M
0.3%
PBYI PUMA BIOTECHNOLOGY, INC.
12 Jun 2017
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% owner indirect
Sold, plan not stated 2×
88,944
$7.05M
2.3%
PBYI PUMA BIOTECHNOLOGY, INC.
9 Jun 2017
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% owner indirect
Sold, plan not stated 2×
58,316
$4.71M
1.5%
PBYI PUMA BIOTECHNOLOGY, INC.
8 Jun 2017
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% owner indirect
Sold, plan not stated 2×
100,000
$8.09M
2.5%
PBYI PUMA BIOTECHNOLOGY, INC.
5 Jun 2017
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% owner indirect
Sold, plan not stated 7×
307,128
$28.04M
7.2%
PBYI PUMA BIOTECHNOLOGY, INC.
2 Jun 2017
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% owner indirect
Sold, plan not stated
30,475
$2.53M
0.7%
PBYI PUMA BIOTECHNOLOGY, INC.
1 Jun 2017
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% owner indirect
Sold, plan not stated 2×
169,525
$13.98M
3.8%
PBYI PUMA BIOTECHNOLOGY, INC.
26 May 2017
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% owner indirect
Sold, plan not stated 3×
300,000
$23.12M
6.3%
PBYI PUMA BIOTECHNOLOGY, INC.
25 May 2017
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% owner indirect
Sold, plan not stated 4×
400,000
$31.15M
7.8%
PBYI PUMA BIOTECHNOLOGY, INC.
24 May 2017
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% owner indirect
Sold, plan not stated 7×
535,700
$38.88M
9.4%
Showing 1–12 of 12.